Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$6.2M
9M shares
52-week range
$0.65 – $2.27
5% from low
Sector
OPHTHALMIC GOODS
Exchange
NASDAQ
CS
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.
www.lucyd.coNo one on the platform currently holds LUCY.
No tracked institution reports a position in LUCY as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-07-18 | 1-for-20reverse |
No one on the platform has traded LUCY yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$LUCY does Lucy pop past a dollar after ER is released?
View on StockTwits ↗$LUCY I'm here. Saw the S1 filing in July and the warrants pricings. Wake up little Lucy🥱 https://www.sec.gov/ix?doc=/Archives/edgar/data/1808377/000182912626007808/innovativeeye_s1.htm
View on StockTwits ↗$SPY $LUCY yall are sleeping on this tiny company. Wait till this news hits the wire. This was only shared on a tiny webull webinar
View on StockTwits ↗$LUCY company hasn’t put out news in 26 days. That seems kind of ridiculous, don’t you think? But you guys that have researched them in depth know way more than I do…
View on StockTwits ↗$LUCY 6mil in revenue, projections of doubling every year, 175 store pilot with a major US retailer(was 50) with 550 stores by q4 and 1000 by end of year, armor with a camera, areos, DHL and oil and gas company pilot, talks with Lowe's and HD...etc... Yet the market is unfazed.
View on StockTwits ↗$LUCY super low volume today, maybe everyone is waiting for earnings report on Aug 12th’ish???
View on StockTwits ↗$LUCY Full-year 2025 revenue increased about 63% year over year to approximately $2.67 million…
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $7M | +148.3% | $-1.23 | $-1.23–$-1.23 | — | 1 |
| 2027 | $22M | +205.6% | $-0.42 | $-0.42–$-0.42 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| LUCYLucyd, Inc | $0.76 | +4.29% | $5M | — |
| APREAprea Therapeutics, Inc. | $0.70 | +2.49% | $9M | — |
| BCDABioCardia, Inc. | $0.88 | +0.43% | $13M | — |
| BMRABiomerica, Inc. | $1.64 | +4.46% | $5M | — |
| CELZCreative Medical Technology Holdings, Inc. | $1.23 | +2.50% | $3M | — |
| CHEKCheck-Cap Ltd. | $1.86 | +1.64% | $11M | — |
| KPRXKiora Pharmaceuticals, Inc. | $2.59 | -1.89% | $11M | — |
Source: Financial Modeling Prep · peers by sector/industry